Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
66.77 USD | -0.01% | +6.00% | +17.64% |
02/05 | Transcript : LeMaitre Vascular, Inc., Q1 2024 Earnings Call, May 02, 2024 | |
02/05 | Earnings Flash (LMAT) LEMAITRE VASCULAR Posts Q1 Revenue $53.5M, vs. Street Est of $51.5M | MT |
Evolution of the average Target Price on LeMaitre Vascular, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering LeMaitre Vascular, Inc.
Stifel Nicolaus | |
Barrington Research | |
JMP Securities | |
Oppenheimer | |
Jefferies & Co. | |
Roth MKM | |
Roth Capital Partners | |
KeyBanc Capital Markets |
EPS Revisions
- Stock Market
- Equities
- LMAT Stock
- Consensus LeMaitre Vascular, Inc.